Specialist Oversight for Global Paediatric Research
UK Hospitals
Hospital Staff Relationships
Years of Experience
While our expertise spans a wide range of complex therapeutic areas, we possess a dedicated capability in the delicate and highly regulated field of paediatric clinical trials. Operating as a global CRO based in the UK, we provide either targeted phase-support or comprehensive, full-service management for studies involving children and adolescents. We partner with biotech and pharmaceutical firms to deliver programmes that are scientifically robust while remaining deeply sensitive to the physical and emotional needs of younger patients and their families.
Navigating the Nuances of Paediatric Studies
Clinical research involving children requires far more than just "scaling down" adult protocols. It demands a specialised approach to dosing, formulation, and safety monitoring.
We design frameworks that prioritise the minimisation of pain and distress, incorporating needle-free sampling or home-health visits where possible, ensuring that the study is operationally realistic for busy families.
Every aspect of the protocol is built around the fundamental principle that children are a vulnerable population, requiring the highest level of protection throughout the research journey.
Scrupulous Rigour in Ethics and Global Compliance
In paediatric research, we must be scrupulously rigorous about the ethical aspects of the programme.
We move beyond basic regulatory compliance, ensuring that every study is underpinned by a robust ethical framework.
A critical part of this is managing the consent and assent process, which is notably complex because it varies significantly from country to country and even site to site.
Our team is expert at navigating these local nuances, understanding at what age a child must provide written assent versus verbal agreement, and which legal guardians must provide formal consent in different jurisdictions.
By working with us, you ensure that your study meets the most stringent ethical standards globally, protecting both the participants and the integrity of your data.
Expert Site Selection and Paediatric Infrastructure
Finding the right environment for a paediatric trial requires a deep understanding of site-level facilities. Through our experience with UK and European sites, we identify the specialist children’s hospitals and dedicated paediatric research units that have the child-friendly environments and trained staff needed for these studies.
Our advantage comes from years of direct collaboration. We know which sites have the administrative agility to set up paediatric studies quickly and which units have the strongest relationships with local family networks. By working with us, you gain access to this local intelligence, ensuring your trial is placed at sites that are technically equipped and ethically prepared.
Frequently Asked Questions
What range of services do you provide for paediatric trials?
We offer a full-service model including Paediatric Investigation Plan (PIP) development, regulatory submissions, site management, and clinical monitoring. Our support covers specific indications ranging from rare genetic disorders to common respiratory conditions.
How do you manage the varying consent and assent requirements globally?
Because we know the international regulatory landscape so intimately, we guide sponsors through the specific legal requirements for each country and site. We manage the development of age-appropriate participant information sheets and assent forms that meet local ethical standards.
Can you handle the regulatory hurdles for paediatric orphan drugs?
Yes. Our team is well-versed in the specific regulatory pathways for paediatric medicines, including the requirements for the MHRA and EMA. We ensure that all safety reporting and ethical documentation meet the highest international standards for vulnerable populations.
How do you minimise the burden on paediatric participants?
We advocate for patient-centric designs that reduce the number of hospital visits and invasive procedures. This includes using micro-sampling techniques, remote monitoring, and providing concierge support for families to ensure high retention rates.
What makes your project teams different from a large, generic CRO?
Continuity and specialised focus. In paediatric research, where building trust with families and sites is critical, having the same senior experts from planning through to close-out prevents delays and ensures that ethical standards are maintained consistently.
Do you support companies with long-term follow-up in paediatric trials?
Absolutely. We have extensive experience in managing the multi-year follow-up studies often required for paediatric therapies, ensuring that long-term safety and developmental data are captured with total precision.
Case Study: Full-Service Delivery of a US-Based Paediatric Respiratory Study
As the full-service partner for a prospective observational programme, we managed a comprehensive Natural History study designed to investigate how Respiratory Syncytial Virus (RSV) infection develops and changes over time in paediatric participants.
This study was conducted exclusively in the United States, requiring our team to manage the specific regulatory, ethical, and data-privacy frameworks of the US healthcare system.
Our role involved the end-to-end coordination of a multi-centre investigation aimed at capturing the real-world progression of the virus in a high-prevalence population.
By leveraging our relationships with US-based clinical sites, we successfully managed the enrolment and longitudinal tracking of the paediatric cohort.
Our senior-led oversight ensured that every data point was captured with total precision, providing the sponsor with the critical evidence base needed to understand the clinical course of the infection and inform the development of future therapeutic and preventative strategies
As the lead partner for this prospective programme, we managed a comprehensive RSV study focused on the specific hurdles of paediatric clinical management.
Our team coordinated a multi-centre effort that prioritised the practicalities of treating young participants, from implementing age-appropriate assent protocols to managing the logistical complexities of paediatric-specific data collection in a fast-moving, high-prevalence environment.
Recognising that paediatric studies demand higher engagement, we leveraged our US site relationships to handle the unique enrolment and retention challenges inherent in longitudinal tracking of infants and children.
Our oversight focused on streamlining the clinical experience for families, ensuring that every data point was captured with precision while navigating the physical and developmental sensitivities of a paediatric cohort.
This approach provided the sponsor with a robust evidence base on the clinical course of RSV, built through a framework that respects the unique requirements of young patients.
TCRS has been a pleasure to work with; the team is attentive to detail, strives to deliver operational excellence, and their engagement style with both the study sponsor and the PIs is with the utmost of professionalism. TCRS staff have a “get it done mindset” and deliver on their commitments; they make themselves available as needed and they make for a great team! Thank you TCRS for being exceptional and versatile! All the best for the next 10 years and many more after that.